Serotonin syndrome in a prisoner.
The authors present a case of serotonin syndrome in a prisoner who was transferred to a psychiatric hospital because of increasing psychotic symptoms. They discuss some factors that appear to put some populations at higher risk for such syndromes, and recommend increased vigilance for such problems in those identified populations.
Zimmerschied
J A
JA
Department of Psychiatry and Neurology, University of Missouri-Columbia, School of Medicine, USA.
Harry
B
B
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D001259:Ataxia / Q000139:chemically induced / Q000503:physiopathology; D003221:Confusion / Q000139:chemically induced / Q000503:physiopathology; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D005555:Forensic Psychiatry; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D017374:Paroxetine / Q000009:adverse effects* / Q000627:therapeutic use; D011329:Prisoners; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors